Abstract
INTRODUCTION

35
Bacterial resistance to antibiotics poses a serious threat to human health and has emerged as a 36 global health concern of the 21st century. At least two million individuals in the United States and is consequently more virulent than the traditional hospital-associated MRSA strains (2, 8, 9) , 48 exacerbates the concern and makes the discovery of new antibiotics urgent.
49
In this vein, we recently described the discovery of a new class of non-β-lactam antibiotics, designated as strain COL I (MIC = 4 μg/mL) and strain COL R (MIC >8 μg/mL) and were 86 subjected to whole-genome sequencing and/or PCR-based DNA sequencing.
87
Antibiotic-susceptibility testing
88
The MIC values of antibiotics were determined using the broth microdilution method of the stimulon, a core and accessory set of cell-wall-associated genes that have been reported to be overexpressed after the exposure of S. aureus to cell-wall-active agents (18, 19, 20) . This 168 observation is consistent with our earlier finding that oxadiazole antibiotics act by inhibiting cell-
169
wall biosynthesis in S. aureus (10). In addition, it suggests that these mutations were likely 170 selected under the pressure of the oxadiazole antibiotic.
171
Of the 13 mutations in structural genes or promoters of the cell-wall-stress stimulon, nine (Table 6) . We also constructed a trx-deletion mutant of strain RN4220 and 248 complemented this deletion mutant by pCNtrx and pCNtrxP70Q. As shown in 
